Lufeng Zheng
Overview
Explore the profile of Lufeng Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo Q, Qin H, Chen Z, Zhang W, Zheng L, Qin T
Genes Dis
. 2025 Mar;
12(3):101311.
PMID: 40034124
The ubiquitin (Ub) system, a ubiquitous presence across eukaryotes, plays a crucial role in the precise orchestration of diverse cellular protein processes. From steering cellular signaling pathways and orchestrating cell...
2.
Zhang Y, Xu H, Han X, Yu Q, Xiao H, Zheng L
Transl Oncol
. 2025 Feb;
53:102285.
PMID: 40015830
No abstract available.
3.
Sun Q, Chang H, Wang H, Zheng L, Weng Y, Zheng D, et al.
J Adv Res
. 2025 Feb;
PMID: 39938794
Background: Extracellular vesicles (EVs) are heterogeneous membranous structures released by various cell types, including large vesicles, microvesicles (MVs), and exosomes. These vesicles play crucial roles in intercellular communication within interstitial...
4.
Zhang Y, Xu H, Han X, Yu Q, Zheng L, Xiao H
Transl Oncol
. 2024 Dec;
52:102267.
PMID: 39740516
Background: Glucose metabolism in breast cancer has a potential effect on tumor progression and is related to the immune microenvironment. Thus, this study aimed to develop a glucose metabolism-tumor microenvironment...
5.
Zheng L, Lu Y, Wang J, Li H
Sci Rep
. 2024 Nov;
14(1):29802.
PMID: 39616173
Considering the fault tolerance of EMB (Electro-Mechanical-Brake) braking failure and anti-rollover control at the same time is one of the urgent problems to be solved in the driving safety of...
6.
Han X, Liu J, Zhang Y, Tse E, Yu Q, Lu Y, et al.
J Pharm Anal
. 2024 Sep;
14(8):100984.
PMID: 39258171
Anlotinib has strong antiangiogenic effects and leads to vessel normalization. However, the "window period" characteristic in regulating vessel normalization by anlotinib cannot fully explain the long-term survival benefits achieved through...
7.
Guo Q, Zhou Y, Ni H, Niu M, Xu S, Zheng L, et al.
J Transl Med
. 2024 Sep;
22(1):832.
PMID: 39256760
Background: The roles of the transcriptional factor SIX2 have been identified in several tumors. However, its roles in gastric cancer (GC) progression have not yet been revealed. Our objective is...
8.
Han X, Qin H, Lu Y, Chen H, Yuan Z, Zhang Y, et al.
Heliyon
. 2024 Aug;
10(14):e34015.
PMID: 39092260
While strides in cancer treatment continue to advance, the enduring challenges posed by cancer metastasis and recurrence persist as formidable contributors to the elevated mortality rates observed in cancer patients....
9.
Zhang J, Luo X, Yang X, Wang B, Zheng L, Yan S
Int Immunopharmacol
. 2024 Jun;
137:112526.
PMID: 38908088
In this study, we identified FOXP3 as a transcription factor for lncRNA SNHG1, which exerts a significant protective role against cardiomyocyte hypertrophy. Through DNA-pull down experiments and ChIP analysis, we...
10.
Lu Y, Han X, Zhang H, Zheng L, Li X
Eur J Pharmacol
. 2024 May;
975:176639.
PMID: 38729415
Anlotinib, an orally administered small molecule inhibitor of receptor tyrosine kinases (RTKs), exerts significant anti-angiogenic and vascular normalization effects. However, the mechanisms underlying its involvement in tumor metabolic reprogramming are...